|
1
|
Luffarelli P, Manna E and Fortunato L:
Epidemiology and risk factors. In: Ductal carcinoma in situ of the
breast. Mariotti C (ed). Springer, Cham, pp23-28, 2017.
|
|
2
|
Chouchane L, Boussen H and Sastry KS:
Breast cancer in Arab populations: Molecular characteristics and
disease management implications. Lancet Oncol. 14:e417–e424.
2013.PubMed/NCBI View Article : Google Scholar
|
|
3
|
El Saghir NS and Abulkhair O: Epidemiology
prevention and management guidelines for breast cancer in Arab
countries. Pan Arab J Oncol. 3:12–18. 2010.
|
|
4
|
World Health Organization: Estimated
Cancer Incidence, Mortality and Prevelence Worldwide in 2012.
Available from urihttp://globocan.iarc.fr/Pages/fact_sheets_population.aspx?country=818simplehttp://globocan.iarc.fr/Pages/fact_sheets_population.aspx?country=818.
Accessed 30 October, 2017.
|
|
5
|
Marmot MG, Altman DG, Cameron DA, Dewar
JA, Thompson SG and Wilcox M: The benefits and harms of breast
cancer screening: An independent review. Br J Cancer.
108:2205–2240. 2013.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Freimanis RI and Yacobozzi M: Breast
cancer screening. NC Med J. 75:117–120. 2014.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Alix-Panabières C, Schwarzenbach H and
Pantel K: Circulating tumor cells and circulating tumor DNA. Annu
Rev Med. 63:199–215. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Elshimali YI, Khaddour H, Sarkissyan M, Wu
Y and Vadgama JV: The clinical utilization of circulating cell free
DNA (CCFDNA) in blood of cancer patients. Int J Mol Sci.
14:18925–18958. 2013.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Vymetalkova V, Cervena K, Bartu L and
Vodicka P: Circulating cell-free DNA and colorectal cancer: A
systematic review. Int J Mol Sci. 19(3356)2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yu M, Stott S, Toner M, Maheswaran S and
Haber DA: Circulating tumor cells: Approaches to isolation and
characterization. J Cell Biol. 192:373–382. 2011.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Zhou Q, Li W, Leng B, Zheng W, He Z, Zuo M
and Chen A: Circulating cell free DNA as the diagnostic marker for
ovarian cancer: A systematic review and meta-analysis. PLoS One.
11(e0155495)2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Rykova EY, Morozkin ES, Ponomaryova AA,
Loseva EM, Zaporozhchenko IA, Cherdyntseva NV, Vlassov VV and
Laktionov PP: Cell-free and cell-bound circulating nucleic acid
complexes: Mechanisms of generation, concentration and content.
Expert Opin Biol Ther. 12 (Suppl 1):S141–S153. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ignatiadis M, Lee M and Jeffrey SS:
Circulating tumor cells and circulating tumor DNA: Challenges and
opportunities on the path to clinical utility. Clin Cancer Res.
21:4786–4800. 2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Schwarzenbach H, Hoon DS and Pantel K:
Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev
Cancer. 11:426–437. 2011.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Malik AN, Shahni R, Rodriguez-de-Ledesma
A, Laftah A and Cunningham P: Mitochondrial DNA as a non-invasive
biomarker: Accurate quantification using real time quantitative PCR
without co-amplification of pseudogenes and dilution bias. Biochem
Biophys Res Commun. 412:1–7. 2011.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Kohler C, Radpour R, Barekati Z,
Asadollahi R, Bitzer J, Wight E, Bürki N, Diesch C, Holzgreve W and
Zhong XY: Levels of plasma circulating cell free nuclear and
mitochondrial DNA as potential biomarkers for breast tumors. Mol
Cancer. 8(105)2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Meddeb R, Dache ZAA, Thezenas S, Otandault
A, Tanos R, Pastor B, Sanchez C, Azzi J, Tousch G, Azan S, et al:
Quantifying circulating cell-free DNA in humans. Sci Rep.
9(5220)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Springer J, Loeffler J, Heinz W,
Schlossnagel H, Lehmann M, Morton O, Rogers TR, Schmitt C, Frosch
M, Einsele H and Kurzai O: Pathogen-specific DNA enrichment does
not increase sensitivity of PCR for diagnosis of invasive
aspergillosis in neutropenic patients. J Clin Microbiol.
49:1267–1273. 2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Sena LA and Chandel NS: Physiological
roles of mitochondrial reactive oxygen species. Mol Cell.
48:158–167. 2012.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Desler C, Marcker ML, Singh KK and
Rasmussen LJ: The importance of mitochondrial DNA in aging and
cancer. J Aging Res. 2011(407536)2011.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Veitia R, Govindaraju D, Bottani S and
Birchler J: Aging: Somatic mutations, epigenetic drift and gene
dosage imbalance. Trends Cell Biol. 27:299–310. 2017.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Doynova MD, Berretta A, Jones MB, Jasoni
CL, Vickers MH and O'Sullivan JM: Interactions between
mitochondrial and nuclear DNA in mammalian cells are non-random.
Mitochondrion. 30:187–196. 2016.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Matta J, Morales L, Ortiz C, Adams D,
Vargas W, Casbas P, Dutil J, Echenique M and Suárez E: Estrogen
receptor expression is associated with DNA repair capacity in
breast cancer. PLoS One. 11(e0152422)2016.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Caldon CE: Estrogen signaling and the DNA
damage response in hormone dependent breast cancers. Front Oncol.
4(106)2014.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Finlay-Schultz J, Gillen AE, Brechbuhl HM,
Ivie JJ, Matthews SB, Jacobsen BM, Bentley DL, Kabos P and
Sartorius CA: Breast cancer suppression by progesterone receptors
is mediated by their modulation of estrogen receptors and RNA
polymerase III. Cancer Res. 77:4934–4946. 2017.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Liou GY and Storz P: Reactive oxygen
species in cancer. Free Radic Res. 44:479–496. 2010.PubMed/NCBI View Article : Google Scholar
|
